Celtium Co., Ltd.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Celtium Co., Ltd. - overview

Established

2020

Location

Gyeonggi-do, -, South Korea

Primary Industry

Biotechnology

About

Founded in 2020 by Sungsu Kim and based in Gyeonggi-do, South Korea, Celtium Co. , Ltd. operates as a manufacturer of therapeutic drugs used to treat diabetic peripheral nerve disease and other nerve disorders. In December 2021, Celtium Co.


, Ltd. raised KRW 5. 5 billion in venture funding from Daekyo Investment, Korea Venture Investment Corporation, SL Investment, Korea University Technology Holdings, Jeonbuk Technology Holdings, and Shinhan Capital. The company develops Precision™ platform, which is designed to optimize the combination of a brain-neurosystem disease model with an automated system.


The platform is tailored to address a spectrum of cranial nervous system diseases, including charcot-marie-tooth disease (CMT), diabetic peripheral neuropathy (DPN), Lou Gehrig's disease (ALS), and chemotherapy-induced peripheral neuropathy (CIPN). The firm’s platform also offers a pathway to develop customized treatments specifically designed to meet the needs of individual patients.


Current Investors

Korea Venture Investment Corporation, SL Investment, Shinhan Capital

Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals, Pharmaceutical Research & Development

Website

www.celltium.com

Company Stage

Early Stage

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.